Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Marcel P. H. van den Broek"'
Autor:
Sarah Grewal, Lior Jankelson, Marcel P. H. van den Broek, Martin Cour, Gloria Bachmann, John B. Kostis, Kamana Misra
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Women have higher risk for developing TdP in response to ventricular repolarization prolonging drugs. Hundreds of trials are administering chloroquine and hydroxychloroquine with/without azithromycin to COVID-19 patients. While an overall prolonged Q
Externí odkaz:
https://doaj.org/article/d774121e43d54b08b30c1dade3154bfd
Autor:
Wouter J. Meijer, Wiete Kromdijk, Marcel P. H. van den Broek, Pieter-Jan A. Haas, Monique C. Minnema, Charles A. Boucher, Dylan W. de Lange, Annemarie M. J. Wensing
Publikováno v:
Case Reports in Infectious Diseases, Vol 2015 (2015)
Immunocompromised patients are at increased risk of complications of influenza virus infection. We report on two critically ill patients on immunosuppressive medication with influenza pneumonia. In both patients, oseltamivir monotherapy did not resul
Externí odkaz:
https://doaj.org/article/9f4305ebb9e14aa6ab240fdc3f9ef021
Autor:
Laurent M A Favié, Floris Groenendaal, Marcel P H van den Broek, Carin M A Rademaker, Timo R de Haan, Henrica L M van Straaten, Peter H Dijk, Arno van Heijst, Jeroen Dudink, Koen P Dijkman, Monique Rijken, Inge A Zonnenberg, Filip Cools, Alexandra Zecic, Johanna H van der Lee, Debbie H G M Nuytemans, Frank van Bel, Toine C G Egberts, Alwin D R Huitema, PharmaCool study group
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211910 (2019)
ObjectiveMorphine is a commonly used drug in encephalopathic neonates treated with therapeutic hypothermia after perinatal asphyxia. Pharmacokinetics and optimal dosing of morphine in this population are largely unknown. The objective of this study w
Externí odkaz:
https://doaj.org/article/d0c808959dbe4a898084ef6b50bb1751
Autor:
Tessa Jaspers, Hylke Jan Kingma, Karina Meijer, Marcel P. H. van den Broek, Patricia M. L. A. van den Bemt, Diego A M Odekerken, Renate C A E van Uden, A.M. Harmsze, Matthijs L. Becker, Ilse Houtenbos
Publikováno v:
European Journal of Clinical Pharmacology
European Journal of Clinical Pharmacology, 77(12), 1919-1926. Springer Verlag
European Journal of Clinical Pharmacology, 77(12), 1919-1926. Springer Verlag
Purpose Treatment schedules for antithrombotic therapy are complex, and there is a risk of inappropriate prescribing or continuation of antithrombotic therapy beyond the intended period of time. The primary aim of this study was to determine the freq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81531bb567b0987ae726717ba7064186
https://doi.org/10.1007/s00228-021-03185-y
https://doi.org/10.1007/s00228-021-03185-y
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics
What is known and objective Trastuzumab‐emtansine is an antibody‐drug conjugate developed to decrease off‐target toxicity. According to the product label, reactions secondary to extravasation are mild or moderate. Case summary We report on a 51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1479fbd67d1d3d01ed8f1bc70e47661d
http://europepmc.org/articles/PMC7383643
http://europepmc.org/articles/PMC7383643
The potential for deprescribing in a palliative oncology patient population: a cross-sectional study
Autor:
Lisanne N van Merendonk, Bas J M Peters, Julia E Möhlmann, Cornelis B Hunting, Elisabeth A Kastelijn, Marcel P H van den Broek
Publikováno v:
European journal of hospital pharmacy : science and practice.
The use of preventive medication in palliative oncology patients may be inappropriate due to limited life expectancy. Deprescribing tools are available but time-consuming and not always tailored to this specific population. Our primary goal was to id
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb9b7988eff4b96176067738df74252
https://pubmed.ncbi.nlm.nih.gov/35197277
https://pubmed.ncbi.nlm.nih.gov/35197277
Autor:
Lior Jankelson, Marcel P H van den Broek, Sarah Grewal, John B. Kostis, Gloria Bachmann, Kamana Misra, Martin Cour
Publikováno v:
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Women have higher risk for developing TdP in response to ventricular repolarization prolonging drugs. Hundreds of trials are administering chloroquine and hydroxychloroquine with/without azithromycin to COVID-19 patients. While an overall prolonged Q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbba68fb9795f7b0e6becc2bd8de14ed
https://pubmed.ncbi.nlm.nih.gov/33102533
https://pubmed.ncbi.nlm.nih.gov/33102533
Publikováno v:
Bijblijven. 34:93-107
Biologische geneesmiddelen, ook wel ‘biologicals’ genoemd, hebben de afgelopen jaren zowel verschillende positieve als negatieve connotaties gekregen. Positief, omdat deze categorie geneesmiddelen vaak heeft geleid tot enorme verbetering van uitk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::677e439692b51c04f14ac0961e6a6f7d
https://doi.org/10.1007/s12414-018-0283-9
https://doi.org/10.1007/s12414-018-0283-9
Autor:
Emanuele de Rinaldis, Dusko Ilic, Magdalena Martinez-Queipo, Sabrina Zeddies, Alka Saxena, Ineke Slaper-Cortenbach, Sophia Aristodemou, Lu Liu, Su M. Lwin, James R. McMillan, Anna E. Martinez, Chrysanthi Ainali, John A. McGrath, Kasper Westinga, Gabriela Petrof, Alyson Guy, Marcel P. H. van den Broek, Rashida Pramanik, Francesco Dazzi, Venu Pullabhatla, Rosamund Nuamah, Linda Ozoemena, Salma Ayis, John B. Mee, Sonia Serrano, Clarisse Maurin, Jemima E. Mellerio, Ellie Rashidghamat, Alexandros Onoufriadis, Tendai Kadiyirire
Publikováno v:
Journal of the American Academy of Dermatology. 83(2)
Background Recessive dystrophic epidermolysis bullosa (RDEB) is a hereditary blistering disorder due to a lack of type VII collagen. At present, treatment is mainly supportive. Objectives To determine whether intravenous allogeneic bone marrow–deri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19b74d22bd28e320030194731978211b
https://pubmed.ncbi.nlm.nih.gov/31786163
https://pubmed.ncbi.nlm.nih.gov/31786163
Autor:
Carla A.F.M. Bruijnzeel-Koomen, F. M. Garritsen, Marcel P. H. van den Broek, Daphne S. Bakker, Marjolein S. de Bruin-Weller, Helen L. Leavis, Jorien van der Schaft
Publikováno v:
Journal of Dermatological Treatment, 29(7), 682. Informa Healthcare
Introduction: Oral immunosuppressive drugs are commonly used in the treatment of atopic dermatitis (AD). In patients with autoimmune- and rheumatic diseases, these drugs have been associated with lymphopenia. Lymphopenia is related to an increased ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4dc665184ef04e6a3f6d467cb4fff06
https://pubmed.ncbi.nlm.nih.gov/29526121
https://pubmed.ncbi.nlm.nih.gov/29526121